Evidence map›Paper›PMID 25767298›Full record

ArticleTetrahedron letters2015

Bioconversion of 6-

Hikaru Kato, Takashi Nakahara, Michitaka Yamaguchi, Ippei Kagiyama, Jennifer M Finefield, James D Sunderhaus, David H Sherman, Robert M Williams, Sachiko Tsukamoto

Open access · greenAbstract read
In one paragraph

Article in Tetrahedron letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Marine Indole Alkaloids.Marine drugs · 2015
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Hikaru KatoGraduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
Takashi NakaharaGraduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
Michitaka YamaguchiGraduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
Ippei KagiyamaGraduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
Jennifer M FinefieldDepartment of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, USA.
James D SunderhausDepartment of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, USA.
David H ShermanLife Sciences Institute and Department of Medicinal Chemistry, The University of Michigan, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, USA.
Robert M WilliamsDepartment of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, USA ; University of Colorado Cancer Center, Aurora, Colorado 80045, USA.
Sachiko TsukamotoGraduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
Kumamoto University · JPColorado State University · USUniversity of Colorado Cancer Center · USUniversity of Michigan–Ann Arbor · US

Funding

TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCESR01CA070375 · NCI · COLORADO STATE UNIVERSITY-FORT COLLINS · PI SHERMAN, DAVID H, WILLIAMS, ROBERT MICHAEL · 1997 to 2018
$4.4M
NCI NIH HHS R01 CA070375
6 · The paper itself

Abstract

We previously described the bioconversion of Notoamide T into (+)-Stephacidin A and (-)-Notoamide B, which suggested that Versicolamide B (

Indexed as

AlkaloidAspergillus spBioconversionNotoamide

Identifiers

PMID25767298
PMCPMC4353397
OpenAlexW2070163163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.